A Rare Complication of a Commonly Used Antihypertensive Agent: Hydralazine-Induced Antineutrophilic Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV) Presenting with Rapidly Progressive Glomerulonephritis (RPGN)

Authors

Kayle Warren, HCA HealthcareFollow
Khiem Vu, HCA HealthcareFollow
Karandeep Shergill, HCA HealthcareFollow
Mohamed Faris, HCA HealthcareFollow

Preview

Division

South Atlantic

Hospital

Grand Strand Medical Center

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2021

Keywords

ANCA-associated vasculitis, AAV, drug-induced vasculitis, case reports

Disciplines

Internal Medicine

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Warren, Kayle; Vu, Khiem; Shergill, Karandeep; and Faris, Mohamed, "A Rare Complication of a Commonly Used Antihypertensive Agent: Hydralazine-Induced Antineutrophilic Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV) Presenting with Rapidly Progressive Glomerulonephritis (RPGN)" (2021). South Atlantic Division Research Day 2021. 34.
https://scholarlycommons.hcahealthcare.com/southatlantic2021/34